Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.
Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.
Inhibitors of urokinase type plasminogen activator and cytostatic activity from crude plants extracts.
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Brain stiffness increases with myelin content.
Individuals with multiple sclerosis redistribute positive mechanical work from the ankle to the hip during walking.
Azo polymeric micelles designed for colon-targeted dimethyl fumarate delivery for colon cancer therapy.
Erratum to: Bone density in proton pump inhibitors users: a prospective study.
A multiple sclerosis-like disorder in patients with OPA1 mutations.
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis.
Mesoscopic Model of Neuronal System Deficits in Multiple Sclerosis.
Oculomotor Nerve Palsy as a Rare Presentation and First Sign of Multiple Myeloma.
[Guidelines for vaccination of immunocompromised individuals].
ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro.
TLR Tolerance as a Treatment for Central Nervous System Autoimmunity.
Multiple sclerosis: experimental models and reality.
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
The MS Center of Saint Louis: a practice perspective of the impacts of high cost sharing.
The environmental risk factors in multiple sclerosis susceptibility: A case-control study.
Motoneuron Death after Human Spinal Cord Injury.
Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
An Approach to Enhance Alignment and Myelination of Dorsal Root Ganglion Neurons.
Thrombomodulin dependent protein C activation is required for mitochondrial function and myelination in the CNS.
Pages
« first
‹ previous
…
768
769
770
771
772
773
774
775
776
…
next ›
last »